Health Care MEDS Earnings: Highlights of Trxade Health’s Q1 2024 financial results 2 years ago Trxade Health, Inc. (NASDAQ: MEDS), a leading health service IT company, reported financial results for the first quarter of 2024.… Alumis looks to raise $300 million in IPO. Here’s what you need to know 2 years ago Technology and healthcare companies are continuing to dominate the IPO market, which is witnessing a significant increase in activity compared… WBA Earnings Preview: Will Walgreens’ Q3 report bring cheer to investors? 2 years ago Walgreens Boots Alliance, Inc. (NASDAQ: WBA) has been facing challenges due to higher operating costs, rising competition, and an unfavorable… Tempus AI gears up for IPO. Here’s everything you need to know 2 years ago The IPO market witnessed stronger activity so far this year compared to the corresponding period last year, with a marked… Ocean Biomedical (NASDAQ: OCEA) Research Summary 2 years ago Ocean Biomedical, Inc. (NASDAQ: OCEA) is a new-generation biotechnology firm that works to accelerate the development of new therapies by… Key metrics from Medtronic’s (MDT) Q4 2024 earnings results 2 years ago Medtronic plc (NYSE: MDT) reported fourth quarter 2024 earnings results today. Worldwide revenue was $8.6 billion, up 0.5% on a… Trxade Health Inc. (NASDAQ: MEDS) Q1 2024 Research Summary 2 years ago Trxade Health, Inc. (NASDAQ: MEDS) is a drug procurement and delivery platform that digitalizes the retail pharmacy experience. The company… Earnings Summary: Organon reports financial results for Q1 2024 2 years ago Pharmaceutical company Organon & Co. (NYSE: OGN) has reported higher revenues and adjusted earnings for the first quarter of 2024.… Cigna Group (CI) reports double-digit revenue growth for Q1; guides FY24 2 years ago The Cigna Group (NYSE: CI), a healthcare company focused on medical insurance and related services, Thursday reported a sharp increase in… Infographic: A snapshot of Moderna’s (MRNA) Q1 2024 earnings results 2 years ago Moderna, Inc. (NASDAQ: MRNA) reported a net loss for the first quarter of 2024 when the biotechnology company's revenues declined… Next» « Previous